Development of a rapid objective tensioning and soft tissue fixation system for ACL reconstruction

Posted on by Ronald Schoengold
View
Event Information

Event Topic:
Development of a rapid objective tensioning and soft tissue fixation system for ACL reconstruction

Event Description:
Tesa Medical, Inc. has developed the GraftGrab™ soft tissue fixation device for use in anterior cruciate ligament (“ACL”) reconstruction. The soft tissue fixation device can set an anterior cruciate ligament (ACL) graft with a single fluid motion and maintain initial graft tensioning, enabling patients to get a quick recovery from knee injuries.

Date/Time:
Date(s) - 03/02/21
8:30 am - 10:30 am

Event Location:
Zoom talk: https://us02web.zoom.us/j/88274227563:

Speaker Information

Event Speaker:
Howard Edelman

Event Speaker Title:
CEO

Event Speaker Company:
Advanced Resin Therapeutics

Event Speaker Bio:
Development of a rapid objective tensioning and soft tissue fixation system for ACL reconstruction
Howard Edelman is a medical device executive accomplished in all aspects of medical product commercialization. Currently, Mr. Edelman is CEO of Tesa Medical, a developer of ACL graft tensioning systems and CEO of Advanced Resin Therapeutics, a developer of a broad-based drug delivery platform based on medical grade plant resins. Previously, Mr. Edelman was General Manager of Cothera, a division of United Orthopedic Group, a global orthopedic devices and patient services company. UOG acquired by Breg in 2014. Mr. Edelman advises a variety of medical device and biotech companies (iDentical, Karuna Labs, Watershed Medical, Pluto Medical, and Carbon Trainer). He is Chairman of the Medical Device and Digital Health screening committee of Life Science Angels and the EIR at the UCSF Innovation Ventures group. Previously, Howard Edelman was the Founder and CEO of VitalWear, a leader in thermal and compression therapy systems. In 2009, VitalWear was named on the INC 500 list of fastest growing private companies and on the San Francisco Business Times Fast 100. Mr. Edelman has served in management roles at Johnson & Johnson, Zeiss, CooperVision, and Bio-Rad Laboratories and various startup companies in the Bay Area. Mr. Edelman sat on the Research Committee for the Juvenile Diabetes Research Foundation. Mr. Edelman holds a B.S. in Biomedical Engineering from Boston University.

Event Details

Cost:
$0

Add To Calendar

0